Opin vísindi

Þögli faraldurinn – sýklalyfjaónæmi

Show simple item record

dc.contributor Landspítali
dc.contributor.author Kristinsson, Karl G
dc.date.accessioned 2022-11-24T01:04:22Z
dc.date.available 2022-11-24T01:04:22Z
dc.date.issued 2022-03-03
dc.identifier.citation Kristinsson , K G 2022 , ' Þögli faraldurinn – sýklalyfjaónæmi ' , Læknablaðið , bind. 108 , nr. 3 , bls. 119 . https://doi.org/10.17992/lbl.2022.03.678
dc.identifier.issn 1670-4959
dc.identifier.other PURE: 62659323
dc.identifier.other PURE UUID: 4461731e-9985-40bd-8a7a-59d401349cbc
dc.identifier.other Scopus: 85125552693
dc.identifier.other unpaywall: 10.17992/lbl.2022.03.678
dc.identifier.uri https://hdl.handle.net/20.500.11815/3659
dc.format.extent 1
dc.format.extent 119
dc.language.iso is
dc.relation.ispartofseries Læknablaðið; 108(3)
dc.rights info:eu-repo/semantics/openAccess
dc.subject Sýklafræði
dc.subject Sýklalyfjaónæmi
dc.subject Anti-Bacterial Agents/adverse effects
dc.subject COVID-19
dc.subject Drug Resistance, Bacterial
dc.subject Humans
dc.subject Pandemics
dc.subject SARS-CoV-2
dc.subject Drug Resistance, Microbial
dc.subject Læknisfræði (allt)
dc.title Þögli faraldurinn – sýklalyfjaónæmi
dc.title.alternative The silent pandemic - antimicrobial resistance
dc.type /dk/atira/pure/researchoutput/researchoutputtypes/contributiontojournal/editorial
dc.identifier.pmid 35230255
dc.identifier.doi https://doi.org/10.17992/lbl.2022.03.678
dc.relation.url http://www.scopus.com/inward/record.url?scp=85125552693&partnerID=8YFLogxK
dc.contributor.department Læknadeild
dc.contributor.department Rannsóknaþjónusta


Files in this item

This item appears in the following Collection(s)

Show simple item record